Please assess the completion status of the following clinical trial:

Trial Title: Combined Phacoemulsification With iStent Inject W Versus Hydrus for Mild to Moderate Open Angle Glaucoma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* \>60 years or older~* Visually significant cataract~* Mild to moderate primary open angle glaucoma controlled on medications~* undergoing cataract surgery with lens implantation and concurrent microstent placement~* IOP ≥ 21 mmHg and ≤ 36 mmHg after washout of ocular hypotensive medication(s)~* CCT 480 to 620μm~* No prior ocular surgery including corneal refractive surgery~* No SLT within 6 months of baseline visit, no history of intracameral glaucoma drug eluting implants~* Visual field mean deviation ≤ -12 dB~* Optic nerve abnormalities consistent with glaucoma, C/D ratio less than ≤0.8~Exclusion Criteria:~* Prior intraocular surgery~* Visual field MD ≥ -12 dB~* secondary glaucoma including uveitis, traumatic, malignant, neovascular, and congenital glaucoma.~* Glaucoma related to elevated episcleral venous pressure including Sturge-Weber syndrome, thyroid eye disease, orbital tumor, and etc.~* Uncontrolled intraocular pressure on maximum tolerated medical therapy;~* Unable to perform wash-out IOP~* Anatomic exclusion of narrow anterior chamber angle (Shaffer grade I-II), other angle abnormalities including angle closure glaucoma~* Corneal disease or dystrophy~* Pathological myopia with degeneration that affects diagnostic imaging~* Clinically significant ocular pathology or degenerative diseases that affect vision, visual field, or optical coherence tomography of optic nerve.~* Inability to perform reliable Visual Field and optical coherence tomography.

- Gender: ALL
- Minimum Age: 60 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Combined cataract surgery with Hydrus microstent (Type: ACTIVE_COMPARATOR): None
- Combined cataract surgery with iStent Inject W (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).